2014
DOI: 10.1097/mou.0000000000000006
|View full text |Cite
|
Sign up to set email alerts
|

What's truly minimally invasive in benign prostatic hyperplasia surgery?

Abstract: Urolift appears to be a well tolerated and effective minimally invasive treatment for lower urinary tract symptoms due to BPH in men who wish to preserve sexual function or who are not suitable for invasive surgery. Further studies will confirm the currently mixed results regarding intraprostatic botulinum toxin or ethanol injections. Rezum, Histotripsy, and Aquablation are experimental treatments under investigation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…While intraprostatic injection of different agents is considered a minimally invasive technique in lower urinary tract symptoms associated with benign prostatic hyperplasia, further studies on the efficacy of more novel agents are needed [12]. Mechanical devices such as Urolift are also emerging for patients who desire to save their sexual function or cannot tolerate surgery [13]. Recently, there has been an increasing interest in novel agents for intraprostatic injection.…”
Section: Discussionmentioning
confidence: 99%
“…While intraprostatic injection of different agents is considered a minimally invasive technique in lower urinary tract symptoms associated with benign prostatic hyperplasia, further studies on the efficacy of more novel agents are needed [12]. Mechanical devices such as Urolift are also emerging for patients who desire to save their sexual function or cannot tolerate surgery [13]. Recently, there has been an increasing interest in novel agents for intraprostatic injection.…”
Section: Discussionmentioning
confidence: 99%
“…New emerging techniques such as UroLift (NeoTract, Inc., Pleasanton, CA, USA), Rezum (N X Thera, Maple Grove, MN, USA), prostatic emolization, and prostatic injectable drugs have gained wide attention in the urologic community. These techniques usually do not remove prostatic tissue immediately, or ever, and only unobstruct a small but seemingly relevant part of the prostatic fossa [4]. Despite encouraging results, the crucial question is, ''How long and for what price?''…”
Section: Experts' Commentsmentioning
confidence: 98%
“…One concern regarding prostatic ethanol ablation is the difficulty in controlling distribution and the potential risk of bladder necrosis due to inadvertent injection [14,15] . Use of anhydrous ethanol in a gel formulation has been described as a potential solution to this problem.…”
Section: Ethanol Ablationmentioning
confidence: 99%